Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

ClinicalTrials.gov ID: NCT06213831

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT06213831. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 12:23 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Maximal Use Trial of Ruxolitinib Cream in Adult Participants With Prurigo Nodularis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study is being conducted to determine the safety and tolerability of ruxolitinib 1.5% cream under maximal use conditions in participants with Prurigo Nodularis (PN).

Study identification

NCT ID
NCT06213831
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Incyte Corporation
Industry
Enrollment
23 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 27, 2024 (Actual)
Primary completion
Jul 17, 2025 (Actual)
Completion
Jul 17, 2025 (Actual)
Last update posted
Aug 13, 2025

2024 – 2025

United States locations

U.S. sites
20
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Saguaro Dermatology Phoenix Arizona 85008 —
Affiliated Dermatology Scottsdale Arizona 85255 —
First Oc Dermatology Fountain Valley California 92708 —
Amicis Research Center Valencia Northridge California 91324 —
Clinical Science Institute Clinical Research Specialists Inc Santa Monica California 90404 —
Advanced Pharma Cr, Llc Miami Florida 33147 —
Sullivan Dermatology North Miami Beach Office North Miami Beach Florida 33162 —
Olympian Clinical Research Tampa Florida 33615 —
St Lukes Clinic Dermatology Ketchum Ketchum Idaho 83340 —
Dawes Fretzin Clinical Research Group Llc Indianapolis Indiana 46250 —
Equity Medical Bowling Green Kentucky 42104 —
Oakland Hills Dermatology Pc Auburn Hills Michigan 48326 —
Revival Research Institute, Llc Troy Troy Michigan 48084 —
Equity Medical, Llc New York New York 10023 —
Red River Research Partners Fargo North Dakota 58103 —
Central Sooner Research Oklahoma City Oklahoma 73170 —
Paddington Testing Co Inc Philadelphia Pennsylvania 19103 —
International Clinical Research Tennessee Llc Murfreesboro Tennessee 37130 —
Dermresearch, Inc. Austin Texas 78759 —
North Texas Center For Clinical Research Ntccr Frisco Texas 75034 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06213831, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 13, 2025 · Synced Nov 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.